Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Biomarker Development in Cardiology: Reviewing the Past to Inform the Future.
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma. N Engl J Med. 2019 01 03; 380(1):45-56.
View in:
PubMed
subject areas
Adult
Aged
Female
Humans
Immunotherapy, Adoptive
Lymphoma, Large B-Cell, Diffuse
Male
Middle Aged
Neoplasm Grading
Receptors, Antigen, T-Cell
Recurrence
Survival Analysis
Young Adult
authors with profiles
Michael Bishop